Bringhurst F R, Stern A M, Yotts M, Mizrahi N, Segre G V, Potts J T
Endocrine Unit, Massachusetts General Hospital, Boston 02114.
J Endocrinol. 1989 Jul;122(1):237-45. doi: 10.1677/joe.0.1220237.
Parathyroid hormone (PTH) is rapidly metabolized, mainly by liver and kidney, to smaller fragments that are believed to be biologically inactive. The significance of this peripheral metabolism in the overall actions of PTH is unclear. Generation of circulating biologically active amino-terminal PTH fragments during metabolism in vivo has been suggested by certain observations in vitro, and what are believed to be amino-terminal fragments may be detectable in blood under pathological circumstances in vivo (such as renal failure and coexistent hyperparathyroidism) when highly sensitive assays are employed. We recently reported, however, that administration to normal rats of [35S]bovine PTH ([35S]bPTH) directly labelled at amino-terminal methionines, followed by high-resolution chromatographic analysis of extracted [35S]peptides, does not result in appearance of radioactive amino-terminal fragments in blood, even when the tracer is continuously infused to near-physiological plasma concentrations. We have now employed these techniques to address a second question regarding hormonal metabolism: is hormonal metabolism modified during metabolic perturbations such as changing calcium availability or altered levels of calciotrophic hormones? Metabolism of [35S-Met]bPTH (900 Ci/mmol), either alone or together with [3H-Pro]bPTH, however, did not lead to alterations in the rate of hormonal clearance nor to detectable circulating amino-terminal fragments, either in calcium-deprived or thyroparathyroidectomized rats or when animals were first rendered intoxicated with vitamin D or maintained on a high calcium intake. Likewise, tissue localization and specific cleavage patterns of intact hormone in liver or kidney were all unaltered by these various manoeuvres.(ABSTRACT TRUNCATED AT 250 WORDS)
甲状旁腺激素(PTH)主要在肝脏和肾脏中迅速代谢为较小的片段,这些片段被认为无生物活性。这种外周代谢在PTH整体作用中的意义尚不清楚。体外的某些观察结果提示,体内代谢过程中会产生具有生物活性的循环氨基末端PTH片段,并且在体内病理情况下(如肾衰竭和并存的甲状旁腺功能亢进),当采用高灵敏度检测方法时,血液中可能检测到被认为是氨基末端的片段。然而,我们最近报道,给正常大鼠注射在氨基末端甲硫氨酸处直接标记的[35S]牛PTH([35S]bPTH),随后对提取的[35S]肽进行高分辨率色谱分析,即使将示踪剂持续输注至接近生理血浆浓度,血液中也不会出现放射性氨基末端片段。我们现在运用这些技术来解决关于激素代谢的第二个问题:在诸如改变钙的可利用性或钙调节激素水平改变等代谢紊乱过程中,激素代谢是否会发生改变?然而,无论是单独给予[35S-甲硫氨酸]bPTH(900 Ci/mmol)还是与[3H-脯氨酸]bPTH一起给予,在钙缺乏或甲状旁腺切除的大鼠中,或者在动物首先用维生素D中毒或维持高钙摄入时,激素清除率均未改变,也未检测到循环氨基末端片段。同样,这些不同的操作均未改变肝脏或肾脏中完整激素的组织定位和特异性裂解模式。(摘要截短至250字)